array:22 ["pii" => "S0213005X2400315X" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2024.09.007" "estado" => "S300" "fechaPublicacion" => "2024-11-01" "aid" => "2893" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Enferm Infecc Microbiol Clin. 2024;42:467" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S0213005X2300191X" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2023.07.004" "estado" => "S300" "fechaPublicacion" => "2024-11-01" "aid" => "2743" "copyright" => "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2024;42:468-77" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original" "titulo" => "Utilidad predictiva de mortalidad de las escalas qSOFA, NEWS y GYM en el paciente anciano con infección en urgencias: estudio EDEN-5" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "468" "paginaFinal" => "477" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Predictive usefulness of qSOFA, NEWS and GYM scores in the elderly patient: EDEN-5 study" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1260 "Ancho" => 1508 "Tamanyo" => 121542 ] ] "descripcion" => array:1 [ "es" => "Resultado de curvas COR de escalas qSOFA, NEWS y GYM. El ABC-COR para mortalidad a los 30 días de la escala NEWS fue 0,765 (IC95%: 0,725-0,806; p<0,001), siendo 0,70 (IC95%: 0,653-0,746) de la escala qSOFA y 0,716 de la escala GYM (IC95%: 0,675-0,758; p<0,001). Las diferencias estadísticas comparando las curvas de rendimiento diagnóstico (COR) fueron: qSOFA vs NEWS p<0,001; GYM vs NEWS p=0,024; qSOFA vs GYM p=0,345." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Eric Jorge García-Lamberechts, Manuel Fuentes Ferrer, Cesáreo Fernández-Alonso, Guillermo Burillo-Putze, Sira Aguiló, Aitor Alquezar-Arbé, Francisco Javier Montero-Pérez, Javier Jacob, Pascual Piñera Salmerón, Manuel Salido Mota, Maria José Marchena, Alba Martínez Alonso, Ana Chacón García, Cristina Güemes de la Iglesia, Osvaldo Jorge Troiano Ungerer, Patricia Eiroa-Hernández, Patricia Parra-Esquivel, Paula Lázaro Aragüés, Patricia Gantes Nieto, Sandra Cuerpo Cardeñosa, Cristina Chacón García, Leticia Serrano Lázaro, María Caballero Martínez, Lara Guillen, Rocío Muñoz Martos, Juan González del Castillo, Òscar Miró" "autores" => array:28 [ 0 => array:2 [ "nombre" => "Eric Jorge" "apellidos" => "García-Lamberechts" ] 1 => array:2 [ "nombre" => "Manuel" "apellidos" => "Fuentes Ferrer" ] 2 => array:2 [ "nombre" => "Cesáreo" "apellidos" => "Fernández-Alonso" ] 3 => array:2 [ "nombre" => "Guillermo" "apellidos" => "Burillo-Putze" ] 4 => array:2 [ "nombre" => "Sira" "apellidos" => "Aguiló" ] 5 => array:2 [ "nombre" => "Aitor" "apellidos" => "Alquezar-Arbé" ] 6 => array:2 [ "nombre" => "Francisco Javier" "apellidos" => "Montero-Pérez" ] 7 => array:2 [ "nombre" => "Javier" "apellidos" => "Jacob" ] 8 => array:2 [ "nombre" => "Pascual" "apellidos" => "Piñera Salmerón" ] 9 => array:2 [ "nombre" => "Manuel" "apellidos" => "Salido Mota" ] 10 => array:2 [ "nombre" => "Maria José" "apellidos" => "Marchena" ] 11 => array:2 [ "nombre" => "Alba" "apellidos" => "Martínez Alonso" ] 12 => array:2 [ "nombre" => "Ana" "apellidos" => "Chacón García" ] 13 => array:2 [ "nombre" => "Cristina" "apellidos" => "Güemes de la Iglesia" ] 14 => array:2 [ "nombre" => "Osvaldo Jorge" "apellidos" => "Troiano Ungerer" ] 15 => array:2 [ "nombre" => "Patricia" "apellidos" => "Eiroa-Hernández" ] 16 => array:2 [ "nombre" => "Patricia" "apellidos" => "Parra-Esquivel" ] 17 => array:2 [ "nombre" => "Paula" "apellidos" => "Lázaro Aragüés" ] 18 => array:2 [ "nombre" => "Patricia" "apellidos" => "Gantes Nieto" ] 19 => array:2 [ "nombre" => "Sandra" "apellidos" => "Cuerpo Cardeñosa" ] 20 => array:2 [ "nombre" => "Cristina" "apellidos" => "Chacón García" ] 21 => array:2 [ "nombre" => "Leticia" "apellidos" => "Serrano Lázaro" ] 22 => array:2 [ "nombre" => "María" "apellidos" => "Caballero Martínez" ] 23 => array:2 [ "nombre" => "Lara" "apellidos" => "Guillen" ] 24 => array:2 [ "nombre" => "Rocío" "apellidos" => "Muñoz Martos" ] 25 => array:2 [ "nombre" => "Juan" "apellidos" => "González del Castillo" ] 26 => array:2 [ "nombre" => "Òscar" "apellidos" => "Miró" ] 27 => array:1 [ "colaborador" => "en representación de la red SIESTA" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2529993X2400008X" "doi" => "10.1016/j.eimce.2024.01.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2529993X2400008X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X2300191X?idApp=UINPBA00004N" "url" => "/0213005X/0000004200000009/v1_202411050552/S0213005X2300191X/v1_202411050552/es/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0213005X23001891" "issn" => "0213005X" "doi" => "10.1016/j.eimc.2023.07.005" "estado" => "S300" "fechaPublicacion" => "2024-11-01" "aid" => "2747" "copyright" => "Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Enferm Infecc Microbiol Clin. 2024;42:484-91" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "484" "paginaFinal" => "491" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Conocimientos, actitudes y prácticas sobre la inflamación crónica y el riesgo cardiovascular relacionados con el VIH en España" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2121 "Ancho" => 1508 "Tamanyo" => 185845 ] ] "descripcion" => array:1 [ "en" => "Biomarkers/therapies most commonly used in the context of chronic inflammation and recommended scales to evaluate cardiovascular risk, according to specialty. (A) Most widely used biomarkers to monitor chronic inflammation. (a) C-reactive protein; (b) D-dimer; (c) Interleukin-6; (d) CD4/CD8 fraction. (B) Most widely recommended therapeutic interventions to reduce chronic inflammation. (a) promote a healthy lifestyle in the patient; (b) recommend changes in ART treatment; (c) initiate treatment with acetylsalicylic acid; (d) intensify statin therapy. (C) Most widely used scales to define cardiovascular risk. (a) DAD scale; (b) Framingham (FGH) scale; (c) FGH scale adapted to the Spanish population; (d) American Heart Association scale (AHA/ACC ASCVD); (e) SCORE European scale; (f) none; (g) other." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sergio Serrano-Villar, José Moltó-Marhuenda, Marta Montero-Alonso, Cesar Diaz-Torné, María López-Cavanillas, Leopoldo Pérez de Isla" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Sergio" "apellidos" => "Serrano-Villar" ] 1 => array:2 [ "nombre" => "José" "apellidos" => "Moltó-Marhuenda" ] 2 => array:2 [ "nombre" => "Marta" "apellidos" => "Montero-Alonso" ] 3 => array:2 [ "nombre" => "Cesar" "apellidos" => "Diaz-Torné" ] 4 => array:2 [ "nombre" => "María" "apellidos" => "López-Cavanillas" ] 5 => array:2 [ "nombre" => "Leopoldo" "apellidos" => "Pérez de Isla" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X23001891?idApp=UINPBA00004N" "url" => "/0213005X/0000004200000009/v1_202411050552/S0213005X23001891/v1_202411050552/en/main.assets" ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "Inflammation in HIV: A persistent challenge" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "467" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Julia Barrado, Vicente Estrada" "autores" => array:2 [ 0 => array:3 [ "nombre" => "Julia" "apellidos" => "Barrado" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Vicente" "apellidos" => "Estrada" "email" => array:2 [ 0 => "vicente.estrada@salud.madrid.org" 1 => "vesda001@gmail.com" ] "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Unidad de Enfermedades Infecciosas, Hospital Clinico San Carlos, IdiSSC, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Investigación en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Universidad Complutense, Madrid, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Inflamación en el VIH: Un reto persistente" ] ] "textoCompleto" => "Inflammation is intrinsic to HIV infection, much like how we were taught that type 2 diabetes is inevitably associated with an increased risk of cardiovascular disease. For reasons whose biological basis is not fully clarified, people living with HIV (PLHIV) who receive antiretroviral treatment (ART) that effectively suppresses viral replication continue to experience a state of low-grade chronic inflammation and immune activation.<a class="elsevierStyleCrossRef" href="#bib0005">1</a> Various causes have been suggested for this: translocation of bacterial products from a partially “permeable” intestine due to persistent and irreversible damage to the mucosal-associated immune tissue, persistent viral replication in a partially active reservoir, alterations in the gut microbiota, or the reactivation of latent infections like CMV, among others.<a class="elsevierStyleCrossRef" href="#bib0010">2</a> This persistent inflammation, unrelated to viremia, which is our best target for disease control, presents a challenge for clinicians who lack practical tools to monitor or treat this issue. Although common inflammatory biomarkers, such as plasma levels of CRP, IL-6, or D-dimer, have shown in numerous clinical studies an association with “hard” variables like mortality, they are not specific enough in clinical practice and can be influenced by many other factors, such as acute infections, autoimmune diseases, cancer, or even circumstances like age, higher body fat, lower physical activity, or smoking. Theoretically, these inflammatory biomarkers could each provide information on a facet of the problem or the origin of the inflammatory process, but their correlation is low, and their combined use offers little clinical value on a day-to-day basis.<a class="elsevierStyleCrossRef" href="#bib0015">3</a>Moreover, even if we had a reliable biomarker, we currently have no means of intervening in it. All attempts to influence inflammation in PLHIV, beyond controlling viral replication, have proven ineffective in practice.<a class="elsevierStyleCrossRef" href="#bib0020">4</a> In this context, Serrano Villar et al.<a class="elsevierStyleCrossRef" href="#bib0025">5</a> have studied the attitudes of different specialists towards chronic inflammation in PLHIV. Internal medicine/Infectious disease specialists seem to have a better understanding of this problem than cardiologists or rheumatologists, to whom they were compared, but they are not the ones acting most proactively on this issue. It is the rheumatologists, used to managing diseases with a strong inflammatory component, who might adopt a more proactive approach, such as monitoring biomarkers or recommending anti-inflammatory drugs, whose rationale is still controversial in HIV but highly useful in the diseases they specialize in.Another interesting finding from this study is the confirmation that years of clinical practice lead to pragmatism. Pragmatism emerged as a philosophical movement in the 19th century in the United States, proposing that only knowledge with practical utility is valid and that, therefore, it is opposed to idealism. Pragmatism is utilitarianism or possibilism: only the useful is worthwhile. Pragmatism leads to skepticism, which is defined as doubt or distrust in the truth or effectiveness of something. In philosophy, skepticism is a theory of knowledge that asserts the nonexistence of truth, or that if it does exist, humans are incapable of knowing it. Trust in science prevents us from being skeptical: we must trust that advances in knowledge will allow us to understand the causes of persistent inflammation in PLHIV, and thus offer a solution. We must trust that not everything has been said about inflammation in HIV: Will there be any progress in the next years in the biology of the viral reservoir that will allow us to achieve a functional cure for HIV? Will we, in the future, be able to intervene at the very initial source of inflammation? We must believe that the answer to these questions is yes and continue to believe in science. The pragmatic attitude of physicians with more years of experience takes us back to the beginning: just as it is inevitable that there is inflammation in HIV or that there is a higher cardiovascular risk in diabetes, we must fight so that it is not inevitable that experienced physicians, in addition to being pragmatic, are also skeptical. In the meantime, let us continue researching inflammation in PLHIV." "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic effects of inflammation on health during chronic HIV infection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.G. Deeks" 1 => "R. Tracy" 2 => "D.C. Douek" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.immuni.2013.10.001" "Revista" => array:6 [ "tituloSerie" => "Immunity" "fecha" => "2013" "volumen" => "39" "paginaInicial" => "633" "paginaFinal" => "645" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24138880" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The many faces of immune activation in HIV-1 infection: a multifactorial interconnection" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Mazzuti" 1 => "O. Turriziani" 2 => "I. Mezzaroma" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/biomedicines11010159" "Revista" => array:5 [ "tituloSerie" => "Biomedicines" "fecha" => "2023" "volumen" => "11" "paginaInicial" => "159" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/36672667" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Watson" 1 => "C. Salisbury" 2 => "P. Whiting" 3 => "J. Banks" 4 => "Y. Pyne" 5 => "W. Hamilton" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3399/bjgp19X704321" "Revista" => array:6 [ "tituloSerie" => "Br J Gen Pract" "fecha" => "2019" "volumen" => "69" "paginaInicial" => "e470" "paginaFinal" => "e478" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31208976" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inflammation in chronic HIV infection: what can we do?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K.M. Erlandson" 1 => "T.B. Campbell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/infdis/jiv007" "Revista" => array:6 [ "tituloSerie" => "J Infect Dis" "fecha" => "2015" "volumen" => "212" "paginaInicial" => "339" "paginaFinal" => "342" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25583171" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Serrano-Villar" 1 => "J. Moltó-Marhuenda" 2 => "M. Montero-Alonso" 3 => "C. Diaz-Torné" 4 => "M. López-Cavanillas" 5 => "L. Pérez de Isla" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Enferm Infecc Microbiol Clin (Engl Ed)" "fecha" => "2024" "volumen" => "42" "paginaInicial" => "484" "paginaFinal" => "491" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/0213005X/0000004200000009/v1_202411050552/S0213005X2400315X/v1_202411050552/en/main.assets" "Apartado" => array:4 [ "identificador" => "8592" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/0213005X/0000004200000009/v1_202411050552/S0213005X2400315X/v1_202411050552/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213005X2400315X?idApp=UINPBA00004N"]

ISSN: 0213-005X

Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.

Ver más Opción Open Access

Indexada en:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Comprar documento

Para la compra de este documento es necesario que rellene el siguiente formulario:

Nombre *

Primer Apellido *

Segundo Apellido

Correo electrónico *

Nombre vía *

Número *

Población *

Afganistan

Albania

Alemania

Andorra

Angola

Anguilla

Antartica

Antigua and barbuda

Antillas holandesas

Arabia saudita

Argelia

Argentina

Armenia

Aruba

Australia

Austria

Azerbaijan

Bahamas

Bahrain

Bangladesh

Barbados

Belarus

Belgica

Belice

Benin

Bermudas/antillas britanicas

Bhutan

Bolivia

Bosnia y herzegowina

Botswana

Brasil

Brunei darussalam

Bulgaria

Burkina faso

Burundi

Cabo verde

Camboya

Camerun

Canada

Chad

Chile

China

Chipre

Colombia

Comoros

Corea

Costa rica

Cote d´ivoire

Croacia

Cuba

Dinamarca

Djibouti

Dominica

East timor

Ecuador

Egipto

El salvador

Emiratos arabes unidos

Eritrea

Escocia

Eslovaquia

Eslovenia

España

Estados federados de micronesia

Estados unidos

Estonia

Etiopia

Fiji

Filipinas

Finlandia

Francia

Gabon

Gambia

Georgia

Ghana

Gibraltar

Grecia

Grenada

Groenlandia

Guadalupe

Guam

Guatemala

Guayana britanica

Guinea

Guinea ecuatorial

Guinea francesa

Guinea-bissau

Haiti

Holanda

Honduras

Hong kong

Hungria

India

Indonesia

Irak

Iran

Irlanda

Isla bouvet

Isla cocos (keeling)

Isla cook

Isla mauricio

Isla navidad

Isla norfolk

Islandia

Islas caiman

Islas falkland (malvinas)

Islas faroe

Islas georgia del sur y sandwich

Islas heard and mc donald

Islas marshall

Islas northern mariana

Islas salomon

Islas svalbard and jan mayen

Islas turks and caicos

Islas united states minor outlyi

Islas virgenes (britanicas)

Islas virgenes (u.s.a.)

Islas wallis and futuna

Israel

Italia

Jamaica

Japon

Jordania

Kazakhstan

Kenia

Kiribati

Kuwait

Kyrgyzstan

Lesoto

Letonia

Libano

Liberia

Libia arab jamahiriya

Liechtenstein

Lituania

Luxemburgo

Macao

Macedonia

Madagascar

Malasia

Malawi

Maldives

Mali

Malta

Marruecos

Martinica

Mauritania

Mayotte

Mexico

Monaco

Mongolia

Monserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Nicaragua

Niger

Nigeria

Niue

Noruega

Nueva caledonia

Nueva zelanda

Oman

Pakistan

Palau

Panama

Papua new guinea

Paraguay

Peru

Pitcairn

Polinesia francesa

Polonia

Portugal

Posesiones gran bretaña

Posesiones u.s.a.

Puerto rico

Qatar

Reino unido

Republica checa

Republica de africa central

Republica de cabo verde

Republica de congo

Republica de corea

Republica de moldova

Republica democratica de laos

Republica democratica del congo

Republica dominicana

Reunion

Ruanda

Rumania

Rusia

Sahara occidental

Saint kitts and nevis

Samoa

Samoa americana

San marino

San tomas y principe

San vincent and the grenadines

Santa lucia

Senegal

Serbia

Seychelles

Sierra leona

Singapur

Siria

Somalia

Sri lanka

St. helena

St. pierre and miquelon

Sudafrica

Sudan

Suecia

Suiza

Surinam

Swaziland

Tailandia

Taiwan republica de china

Tajikistan

Tanzania

Territorio de indias britanicas

Togo

Tokelau

Tonga

Trinidad and tobago

Tunisia

Turkmenistan

Turquia

Tuvalu

Ucrania

Uganda

Uruguay

Uzbekistan

Vanuatu

Vaticano

Venezuela

Vietnam

Yemen

Yugoslavia

Zambia

Zimbawe

Lebanon

Paises bajos

A coruña

Alava

Albacete

Alicante

Almeria

Asturias

Avila

Badajoz

Balears

Barcelona

Bizkaia

Burgos

Caceres

Cadiz

Cantabria

Castellon

Ceuta

Ciudad real

Cordoba

Cuenca

Girona

Granada

Guadalajara

Guipuzcoa

Huelva

Huesca

Jaen

La rioja

Las palmas

Leon

Lleida

Lugo

Madrid

Malaga

Melilla

Murcia

Navarra

Ourense

Palencia

Pontevedra

Salamanca

Segovia

Sevilla

Soria

Tarragona

Tenerife

Teruel

Toledo

Valencia

Valladolid

Zamora

Zaragoza

-- No procede --

Código postal *

Teléfono *

NIF o número identificativo *

Deseo recibir información sobre productos y promociones especiales de Elsevier por correo electrónico

Deseo recibir información sobre productos y promociones especiales de los partners de Elsevier por correo electrónico

Acepto la Política de Privacidad y los términos y condiciones

* Campos obligatorios

Además del acceso temporal al artículo, este le será enviado por correo electrónico.

Atención al cliente

Teléfono

Llamadas desde España

932 415 960

Llamadas desde el extranjero

+34 932 415 960

Horario de 9 a 18h. excepto los meses de julio y agosto que será de 9 a 15h.

Publique en

Enfermedades Infecciosas y Microbiología Clínica

Artículos de acceso gratuito

Outpatient parenteral antibiotic therapy (OPAT)...

10.1016/j.eimc.2024.04.001

Corrigendum a: Ecografía clínica:...

Enferm Infecc Microbiol Clin. 2024;42:281

The current status of arboviruses with major...

Enferm Infecc Microbiol Clin. 2024;42:516-26

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica sigue las recomendaciones para la preparación, presentación y publicación de trabajos académicos en revistas biomédicas

Indexada en:

Síguenos:

Suscribirse:

Comprar documento

Indexada en:

Síguenos:

Suscribirse:

Comprar documento

Suscríbase a la newsletter